(Q43688419)

English

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study

scientific article published on 12 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study (English)

1 reference

Europe PubMed Central

25 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

acute pancreatitis

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Carlo Bruno Giorda

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Roberta Picariello

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Elisa Nada

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Barbara Tartaglino

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Lisa Marafetti

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Giuseppe Costa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

12 November 2013

1 reference

Europe PubMed Central

25 November 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

111-115

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622714%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin-induced pancreatitis: A possible adverse drug effect during acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin induced acute pancreatitis precipitated by renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A cohort study of acute pancreatitis in relation to exenatide use.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of validated methods for identifying pancreatitis using administrative data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Q: Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

GLP-1-based therapy for diabetes: what you do not know can hurt you.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

GLP-1 based agents and acute pancreatitis : drug safety falls victim to the three monkey paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970147-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43688419&oldid=2102523136"